DE69832156D1 - Zusammensetzungen und verfahren des synaptischen aktivierungsproteins - Google Patents

Zusammensetzungen und verfahren des synaptischen aktivierungsproteins

Info

Publication number
DE69832156D1
DE69832156D1 DE69832156T DE69832156T DE69832156D1 DE 69832156 D1 DE69832156 D1 DE 69832156D1 DE 69832156 T DE69832156 T DE 69832156T DE 69832156 T DE69832156 T DE 69832156T DE 69832156 D1 DE69832156 D1 DE 69832156D1
Authority
DE
Germany
Prior art keywords
proteins
sequence
synaptic activation
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69832156T
Other languages
English (en)
Other versions
DE69832156T2 (de
Inventor
F Worley
R Brakeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Application granted granted Critical
Publication of DE69832156D1 publication Critical patent/DE69832156D1/de
Publication of DE69832156T2 publication Critical patent/DE69832156T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69832156T 1997-03-14 1998-03-13 Zusammensetzungen des synaptischen Aktivierungsproteins und Verfahren Expired - Fee Related DE69832156T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3655397P 1997-03-14 1997-03-14
US36553P 1997-03-14
PCT/US1998/004983 WO1998040407A1 (en) 1997-03-14 1998-03-13 Synaptic activation protein compositions and method

Publications (2)

Publication Number Publication Date
DE69832156D1 true DE69832156D1 (de) 2005-12-08
DE69832156T2 DE69832156T2 (de) 2006-08-03

Family

ID=21889236

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69832156T Expired - Fee Related DE69832156T2 (de) 1997-03-14 1998-03-13 Zusammensetzungen des synaptischen Aktivierungsproteins und Verfahren

Country Status (9)

Country Link
US (3) US6294355B1 (de)
EP (1) EP0970119B9 (de)
JP (1) JP4127861B2 (de)
AT (1) ATE308564T1 (de)
AU (1) AU733575B2 (de)
CA (1) CA2287591A1 (de)
DE (1) DE69832156T2 (de)
ES (1) ES2255152T3 (de)
WO (1) WO1998040407A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1115860A2 (de) * 1998-09-25 2001-07-18 Incyte Genomics, Inc. Membran-assoziierte organisatorische proteine
EP1027890A3 (de) * 1998-12-16 2000-09-06 Knoll Aktiengesellschaft Homer ein neues Ziel für die Behandlung von psychiatrischen Krankheiten
US6942981B1 (en) 1999-05-14 2005-09-13 Arbor Vita Corporation Method of determining interactions with PDZ-domain polypeptides
GB0005700D0 (en) * 2000-03-09 2000-05-03 Glaxo Group Ltd Therapy
US7442513B2 (en) * 2002-06-19 2008-10-28 The Johns Hopkins University Method of screening for agents that modulate a homer signaling pathway
WO2012058201A2 (en) 2010-10-26 2012-05-03 President And Fellows Of Harvard College Method for determining activators of excitatory synapse formation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767252A (en) 1996-04-08 1998-06-16 The Johns Hopkins University School Of Medicine Neuronal cell growth factor, Narp

Also Published As

Publication number Publication date
EP0970119A4 (de) 2004-09-29
DE69832156T2 (de) 2006-08-03
ES2255152T3 (es) 2006-06-16
US6294355B1 (en) 2001-09-25
US20040229274A1 (en) 2004-11-18
EP0970119A1 (de) 2000-01-12
AU6702698A (en) 1998-09-29
WO1998040407A1 (en) 1998-09-17
US6780600B2 (en) 2004-08-24
CA2287591A1 (en) 1998-09-17
JP2001517217A (ja) 2001-10-02
JP4127861B2 (ja) 2008-07-30
ATE308564T1 (de) 2005-11-15
EP0970119B9 (de) 2006-06-28
US7399830B2 (en) 2008-07-15
US20030027147A1 (en) 2003-02-06
AU733575B2 (en) 2001-05-17
EP0970119B1 (de) 2005-11-02

Similar Documents

Publication Publication Date Title
Aota et al. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function.
CA2395724A1 (en) NUCLEIC ACIDS, PROTEINS AND ANTIBODIES
ZA200803403B (en) Botulinum neurotoxin a protein receptor and use thereof
IL191077A0 (en) An isolated antibody which binds to the n-terminal domain of gamma-heregulin and methods using it
BR9507618A (pt) Frações polipeptidicas solúveis da proteína lag-3 processo de produção composição terapêutica anticorpos anti-idiotipo
PT1007654E (pt) Biblioteca de expressao de proteina ou peptido in vitro
DE69936453D1 (de) Für einen g-protein gekoppelten rezeptor, der an der empfindungstransduktion beteiligt ist, kodierende nukleinsäuren
PT907731E (pt) Receptores gaba[b] metabotropicos, ligandos especificos dos receptores e suas utilizacoes
SE9704836D0 (sv) Novel receptor
BR9912545A (pt) ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial
DE602005019495D1 (de) Ligand für den Formylpeptidrezeptorähnlichen- 2 (FPRL2) G Protein gekoppelten Rezeptor und dessen Anwendung
WO1997024436A3 (en) Ligand polypeptides for the g-protein-coupled receptor protein, their production and use
ATE483806T1 (de) Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptide
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
CY1108568T1 (el) Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α
ATE323771T1 (de) Fragment des menschlichen erythropoietinrezeptors und antikörper dagegen
ATE372384T1 (de) Protein-tyrosin-phosphatase ptp-s31
DE69832156D1 (de) Zusammensetzungen und verfahren des synaptischen aktivierungsproteins
DE69938240D1 (de) Neuer g-protein-gekoppelter rezeptor
ATE407208T1 (de) Hemopoietin-rezeptor
IL146450A0 (en) Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction
WO2002026930A3 (en) Nucleic acids, proteins, and antibodies
ATE449171T1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
EP1578953A4 (de) Verfahren zur bestimmung der primärstruktur der für die rekombinante menschliche endooligopeptidase a (heopa) codierenden boten-rna ¬af217798|...
WO2005077975A3 (en) Polypeptides comprising the pleckstrin homology domain of ect2 and their binding specificities to phosphatidylinositols

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee